Our mission
Announce news
Subscribe
← Latest venture news
Discover UK startups operating in the
Biotechnology
sector
-
AMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution
Strategic
Biotechnology
Feb 11, 2026
🔗
amplydiscovery.com
£4.8m
NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions
Equity
Biotechnology
Feb 5, 2026
🔗
nu-vision.co.uk
£170m
Tenpoint Therapeutics unlocks a £170m Series B from investors to rejuvenate vision in the aging eye
Series B
Biotechnology
Jan 29, 2026
🔗
tenpointtherapeutics.com
£1.7m
Anzen Industries secures a £1.7m pre-seed round led by LocalGlobe and Creator Fund to reinvent how critical molecules are made
Pre-seed
Biotechnology
Jan 19, 2026
🔗
anzenindustries.com
£4m
Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs
Seed
Biotechnology
Jan 13, 2026
🔗
allos.ai
£2m
Axol Bioscience announces £2m in funding led by BroadOak Capital Partners to supply stem cell-derived disease models
Equity
Biotechnology
Jan 13, 2026
🔗
axolbio.com
£9m
Nuclera lands £9m Series C extension led by Elevage Medical Technologies to speed up synthesising functional proteins
Extension
Biotechnology
Jan 13, 2026
🔗
nuclera.com
£2.5m
OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
Seed
Biotechnology
Jan 12, 2026
🔗
outsee.co.uk
£40m
bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology
Series C
Biotechnology
Jan 10, 2026
🔗
bit.bio
£20m
Engitix raises £20m Series A extension from Netherton Investments to develop therapies for cancer and fibrosis
Extension
Biotechnology
Jan 8, 2026
🔗
engitix.com
-
Relation secures £40m in strategic backing from Novartis to advance drug discovery for atopic diseases
Strategic
Biotechnology
Dec 11, 2025
🔗
relationrx.com
£25m
EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy
Series A
Biotechnology
Dec 10, 2025
🔗
epilepsygtx.com
£3m
HotHouse Therapeutics emerges from stealth with £3m pre-seed led by SynBioVen to develop plant-based drug compounds
Pre-seed
Biotechnology
Dec 2, 2025
🔗
hothousetx.com
£10m
Biocentis raises £10m seed round led by The Grantham Foundation and Algebris Investments to develop biotech insect control solutions
Seed
Biotechnology
Nov 21, 2025
🔗
biocentis.com
£2m
InvenireX secures £2m in seed funding led by DSW Ventures to accelerate DNA nanotechology detection
Seed
Biotechnology
Nov 18, 2025
🔗
invenirex.co.uk
£90m
Artios Pharma lands £90m Series D led by SV Health Investors and RA Capital Management to advance DNA damage response therapeutics
Series D
Biotechnology
Nov 18, 2025
🔗
artios.com
£9m
Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery
Seed
Biotechnology
Nov 14, 2025
🔗
scriptatherapeutics.com
£24m
T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
Extension
Biotechnology
Nov 13, 2025
🔗
t-therapeutics.com
£50m
Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis
Series A
Biotechnology
Oct 22, 2025
🔗
elevara.com
£37m
Chemify raises £37m Series B led by Wing Venture Capital and Insight Partners to digitise chemistry for drug and materials discovery
Series B
Biotechnology
Oct 21, 2025
🔗
chemify.io
£5m
Cyclana Bio raises £5m pre-seed led by NfX and Eka VC to advance drug discovery for endometriosis through tissue-level therapeutics
Pre-seed
Biotechnology
Oct 20, 2025
🔗
cyclanabio.com
£10m
Mission Therapeutics raises £10m in follow-on funding from investors to advance mitophagy-based Parkinson’s therapy
Follow-on
Biotechnology
Oct 15, 2025
🔗
missiontherapeutics.com
£70m
Trogenix raises £70m Series A led by IQ Capital to advance precision cancer therapies into clinical trials
Series A
Biotechnology
Oct 6, 2025
🔗
trogenix.com
£3.5m
Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions
Equity
Biotechnology
Oct 2, 2025
🔗
athernalbio.com
£2m
Forge Genetics raises £2m from Mercia Ventures for gene-editing tool offering safer alternative to CRISPR
Equity
Biotechnology
Oct 1, 2025
🔗
forgegenetics.com
£4m
Scindo lands £4m in funding from Kadmos Capital and Clay Capital to develop enzyme platform for sustainable chemicals
Equity
Biotechnology
Sep 23, 2025
🔗
scindo.bio
£14m
Enhanced Genomics raises £14m Series A from investors to advance therapeutics pipeline with its 3D multi-omics platform
Series A
Biotechnology
Sep 16, 2025
🔗
enhancedgenomics.com
£24m
Alchemab Therapeutics raises £24m Series A extension led by Ono Venture Investment to advance AI-enabled antibody platform
Follow-on
Biotechnology
Sep 9, 2025
🔗
alchemab.com
£2.5m
BoobyBiome secures £2.5m seed round led by Empirical Ventures to advance breast milk microbiome tech
Seed
Biotechnology
Sep 8, 2025
🔗
boobybiome.com
£50m
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
Series B
Biotechnology
Sep 8, 2025
🔗
nrgtherapeutics.com
Next